多重基因编辑增强地中海贫血CD34+细胞HbF再激活
本研究在地中海贫血成人CD34+细胞中探索联合顺式和反式基因编辑靶点以增强胎儿血红蛋白(HbF)再激活。多重诱变在体外和体内均耐受良好,不影响细胞增殖与分化。联合一个反式和一个顺式突变在NBSGW小鼠中实现高编辑保留和几乎全细胞HbF表达,且该效果通过新型HD-Ad-dualCRISPR载体在β-地中海贫血患者CD34+细胞中得到验证,提示联合编辑可能优于单编辑策略。
要点
- 联合顺式和反式编辑靶点可协同增强HbF表达。
- 多重编辑不影响CD34+细胞增殖和分化。
- HD-Ad-dualCRISPR载体可在体内递送双编辑。
核心结论
- 联合顺式和反式胎儿珠蛋白再激活突变可能比单编辑显著提高总HbF及单细胞HbF水平。
研究设计与样本
- 在成人CD34+细胞中进行多重诱变,并在体外和NBSGW小鼠体内评估。
- 使用新型HD-Ad-dualCRISPR载体在β-地中海贫血患者CD34+细胞及已建立β0/β0-地中海贫血造血的小鼠中验证。
主要发现
- 多重诱变在体外和体内均耐受良好,未检测到细胞增殖和分化缺陷。
- 一个反式突变联合一个顺式突变在NBSGW小鼠中实现高编辑保留和几乎全细胞HbF表达。
- 在β-地中海贫血患者CD34+细胞移植的NBSGW小鼠中,HD-Ad-dualCRISPR载体重现了联合编辑的优越体内表现。
- 在已建立 predominant β0/β0-地中海贫血造血的小鼠中,体内注射HD-Ad-dualCRISPR载体后,人红细胞HbF表达显著增加。
临床怎么用
- 联合顺式和反式编辑策略可能为严重β-珠蛋白表型患者提供显著临床获益。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Thalassemia or sickle cell patients with hereditary persistence of fetal hemoglobin (HbF) have an ameliorated clinical phenotype and, in some cases, can achieve transfusion independence. Inactivation via genome editing of γ-globin developmental suppressors, such as BCL11A or LRF/ZBTB7A, or of their binding sites, have been shown to significantly increase expression of endogenous HbF. To broaden the therapeutic window beyond a single-editing approach, we have explored combinations of cis- and trans-editing targets to enhance HbF reactivation. Multiplex mutagenesis in adult CD34+ cells was well tolerated and did not lead to any detectable defect in the cells' proliferation and differentiation, either in vitro or in vivo. The combination of 1 trans and 1 cis mutation resulted in high editing retention in vivo, coupled with almost pancellular HbF expression in NBSGW mice. The greater in vivo performance of this combination was also recapitulated using a novel helper-dependent adenoviral-CRISPR vector (HD-Ad-dualCRISPR) in CD34+ cells from β-thalassemia patients transplanted to NBSGW mice. A pronounced increase in HbF expression was observed in human red blood cells in mice with established predominant β0/β0-thalassemic hemopoiesis after in vivo injection of the HD-Ad-dualCRISPR vector. Collectively, our data suggest that the combination of cis and trans fetal globin reactivation mutations has the potential to significantly increase HbF both totally and on a per cell basis over single editing and could thus provide significant clinical benefit to patients with severe β-globin phenotype.
引用
- Psatha N, Georgakopoulou A, Li C, et al. Enhanced HbF reactivation by multiplex mutagenesis of thalassemic CD34+ cells in vitro and in vivo. Blood. 2021. PMID: 34086867. doi:10.1182/blood.2020010020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。